Is Rekah Pharmaceutical Industry (TLV:REKA) A Risky Investment?
May 27
Have your own idea? Try our Stock Screener
Israeli (TA) Pharma Industry Analysis
UpdatedMay 30, 2025
DataAggregated Company Financials
Companies8
- 7D0.3%
- 3M-7.1%
- 1Y-40.5%
- YTD-10.1%
Over the last 7 days, the Pharma industry has dropped 2.0%, driven by a pullback from InterCure of 4.1%. On the other hand Tikun Olam-Cannbit Pharmaceuticals is actually up 7.4%. However, the industry is down 43% over the past year.
Industry Valuation and Performance
Has the Israeli Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 30 May 2025 | ₪594.0m | ₪730.2m | -₪68,483,900.40 | 15.8x | -8.7x | 0.8x |
| Sun, 27 Apr 2025 | ₪576.6m | ₪766.6m | -₪80,204,008.00 | 14.8x | -7.2x | 0.8x |
| Tue, 25 Mar 2025 | ₪601.0m | ₪828.6m | -₪165,194,616.00 | 19.5x | -3.6x | 0.7x |
| Thu, 20 Feb 2025 | ₪679.5m | ₪828.6m | -₪179,982,708.20 | 22.3x | -3.8x | 0.8x |
| Sat, 18 Jan 2025 | ₪689.1m | ₪828.6m | -₪180,135,428.00 | 20.8x | -3.8x | 0.8x |
| Mon, 16 Dec 2024 | ₪617.7m | ₪828.6m | -₪180,537,629.00 | 20.8x | -3.4x | 0.7x |
| Wed, 13 Nov 2024 | ₪598.1m | ₪816.0m | -₪201,060,894.90 | 24.8x | -3x | 0.7x |
| Fri, 11 Oct 2024 | ₪654.3m | ₪808.7m | -₪205,946,772.30 | 24x | -3.2x | 0.8x |
| Sun, 08 Sep 2024 | ₪706.8m | ₪810.4m | -₪244,091,836.20 | 23.6x | -2.9x | 0.9x |
| Tue, 06 Aug 2024 | ₪614.4m | ₪901.7m | -₪264,870,310.80 | n/a | -2.3x | 0.7x |
| Thu, 04 Jul 2024 | ₪644.2m | ₪901.7m | -₪263,553,078.00 | n/a | -2.4x | 0.7x |
| Sat, 01 Jun 2024 | ₪833.6m | ₪886.2m | -₪256,477,710.00 | n/a | -3.3x | 0.9x |
| Mon, 29 Apr 2024 | ₪788.7m | ₪956.4m | -₪181,429,252.00 | 21.8x | -4.3x | 0.8x |
| Wed, 27 Mar 2024 | ₪755.2m | ₪972.3m | -₪208,421,080.00 | 20x | -3.6x | 0.8x |
| Fri, 23 Feb 2024 | ₪653.1m | ₪972.3m | -₪212,067,091.60 | 14.7x | -3.1x | 0.7x |
| Sun, 21 Jan 2024 | ₪588.3m | ₪972.3m | -₪214,440,892.00 | 11.8x | -2.7x | 0.6x |
| Tue, 19 Dec 2023 | ₪580.7m | ₪972.3m | -₪212,667,387.00 | 9.9x | -2.7x | 0.6x |
| Thu, 16 Nov 2023 | ₪557.4m | ₪958.8m | -₪209,146,631.00 | 9x | -2.7x | 0.6x |
| Sat, 14 Oct 2023 | ₪623.5m | ₪958.8m | -₪213,245,938.00 | 11.5x | -2.9x | 0.7x |
| Mon, 11 Sep 2023 | ₪660.5m | ₪958.8m | -₪210,645,818.00 | 13.6x | -3.1x | 0.7x |
| Wed, 09 Aug 2023 | ₪692.3m | ₪918.8m | -₪126,927,754.00 | 9.1x | -5.5x | 0.8x |
| Fri, 07 Jul 2023 | ₪638.6m | ₪918.8m | -₪126,887,331.00 | 8.2x | -5x | 0.7x |
| Sun, 04 Jun 2023 | ₪759.5m | ₪912.7m | -₪127,900,655.00 | 10.3x | -5.9x | 0.8x |
| Tue, 02 May 2023 | ₪818.8m | ₪887.2m | -₪121,107,158.00 | 8.4x | -6.8x | 0.9x |
| Thu, 30 Mar 2023 | ₪780.7m | ₪815.6m | -₪70,345,770.00 | 11.8x | -11.1x | 1x |
| Sat, 25 Feb 2023 | ₪928.4m | ₪815.6m | -₪72,187,550.00 | 13.7x | -12.9x | 1.1x |
| Mon, 23 Jan 2023 | ₪1.0b | ₪739.7m | -₪55,122,650.00 | 17.7x | -19x | 1.4x |
| Wed, 21 Dec 2022 | ₪1.1b | ₪739.7m | -₪56,640,588.00 | 19.4x | -18.9x | 1.4x |
| Fri, 18 Nov 2022 | ₪1.3b | ₪728.3m | -₪57,019,825.00 | 23.2x | -22.4x | 1.8x |
| Sun, 16 Oct 2022 | ₪1.3b | ₪689.4m | -₪61,017,663.00 | 31.2x | -21.1x | 1.9x |
| Tue, 13 Sep 2022 | ₪1.4b | ₪785.2m | -₪109,641,523.00 | 30.9x | -12.9x | 1.8x |
| Thu, 11 Aug 2022 | ₪1.7b | ₪731.4m | -₪115,198,437.00 | 44.3x | -14.4x | 2.3x |
| Sat, 09 Jul 2022 | ₪1.6b | ₪731.4m | -₪119,563,495.00 | 44.4x | -13.5x | 2.2x |
| Mon, 06 Jun 2022 | ₪1.7b | ₪731.4m | -₪117,125,090.00 | 42.3x | -14.9x | 2.4x |
Price to Earnings Ratio
-14.9x
Current Industry PE
- Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 1.0x is higher than the industry's current PS ratio of 0.80x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | 3.30% | |
| Healthcare | -0.67% | |
| Pharma | 0.35% | |
| Pharma | 0.35% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SEMG Seach Medical Group | ₪2.75 | 2.6% +₪2.3m | 77.5% | PE6.1x | |
| TKUN Tikun Olam-Cannbit Pharmaceuticals | ₪0.39 | 2.9% +₪934.6k | 5.7% | PS1x | |
| REKA Rekah Pharmaceutical Industry | ₪13.83 | 0.4% +₪684.9k | 6.6% | PE25.4x | |
| INCR InterCure | ₪5.65 | 0.1% +₪283.0k | -49.4% | PS1.1x | |
| YBRD Y.B Urban Renewal - Residential Development | ₪4.99 | -0.2% ₪210.4k | -70.8% | PS33.6x |